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Abstract Membrane proteins serve as cellular gatekeep-
ers, regulators, and sensors. Prior studies have explored the
functional breadth and evolution of proteins and families of
particular interest, such as the diversity of transport-asso-
ciated membrane protein families in prokaryotes and
eukaryotes, the composition of integral membrane proteins,
and family classiﬁcation of all human G-protein coupled
receptors. However, a comprehensive analysis of the con-
tent and evolutionary associations between membrane
proteins and families in a diverse set of genomes is lacking.
Here, a membrane protein annotation pipeline was devel-
oped to deﬁne the integral membrane genome and associ-
ations between 21,379 proteins from 34 genomes; most, but
not all of these proteins belong to 598 deﬁned families. The
pipeline was used to provide target input for a structural
genomics project that successfully cloned, expressed, and
puriﬁed 61 of our ﬁrst 96 selected targets in yeast. Fur-
thermore, the methodology was applied (1) to explore the
evolutionary history of the substrate-binding transmem-
brane domains of the human ABC transporter superfamily,
(2) to identify the multidrug resistance-associated mem-
brane proteins in whole genomes, and (3) to identify
putative new membrane protein families.
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Abbreviations
CSMP Center for the Structures of Membrane Proteins
PMT Pharmacogenetics of Membrane Transporters
ABC ATP-binding cassette
SLC Solute carrier
IMG Integral membrane genome
IMP Integral membrane protein
TMH Transmembrane helix
PSSM Position-speciﬁc scoring matrix
DDM n-dodecyl-b-D-maltopyranoside
Introduction
Integral membrane proteins perform a variety of critical
cellular functions, such as protecting the cell from
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DOI 10.1007/s10969-009-9069-8external toxins, acting as the starting point of intracellular
signaling cascades, and maintaining critical ion concen-
trations. They make up approximately 20–30% of an
organism’s genome [4, 27]. Bioinformatics methods allow
us to predict with better than 90% accuracy [12] all
a-helical transmembrane proteins in the wealth of
sequenced genomes [21].
Membrane proteins are generally difﬁcult to work with
experimentally, which leads to incomplete annotation of
their functions. Important prior work focusing on membrane
protein families includes an analysis of membrane protein
fold space [28], the computational analysis ofthe membrane
protein space (CAMPS) database of membrane proteins
from bacteria (http://webclu.bio.wzw.tum.de/binfo/proj/
camps)[ 25], the transporter-speciﬁc databases TCDB
(http://www.tcdb.org/)[ 33] and TransportDB (http://www.
membranetransport.org/)[ 32], and the G-protein coupled
receptor database GPCRDB (http://www.gpcr.org/7tm/)
[17]. However, a comprehensive analysis of the content and
evolutionary associations between membrane proteins and
families in a diverse set of genomes is lacking.
Classiﬁcation schemes for protein families vary;
sequence and structure data can be used separately or in
combination with each other to cluster sequences auto-
matically (ProDom [35]) or manually (Pfam-A [11]; SCOP
[1]). Less than 1% of the structures in the protein data bank
(PDB) are high-resolution structures of membrane-bound
proteins [40], providing only sparse data for structure-
based functional annotation. In contrast, sequence
databases are growing rapidly, thus expanding the universe
of known membrane protein families and folds. Improved
structural, functional, and evolutionary annotation of
membrane proteins is essential to exploit this sequence
information.
Here, an automated, sequence- and structure-based
approach was taken to deﬁne the integral membrane pro-
tein set of an organism. In particular, the bioinformatics
analysis underpins the Center for Structures of Membrane
Proteins (CSMP; http://csmp.ucsf.edu) as well as the
Center for Pharmacogenetics of membrane transporters
(PMT; http://pharmacogenetics.ucsf.edu).
For CSMP, a list of protein targets was constructed for
the structural genomics of membrane proteins (see the
accompanying paper [23]). The project took a genome-
wide approach, using yeast as a model organism, to tackle
as many unique membrane protein families as possible. For
PMT, the focus was on identifying and analyzing speciﬁ-
cally the ATP-binding cassette (ABC) and solute carrier
(SLC) transporter superfamilies. The overall goal is to
leverage the cataloging and annotation of human genetic
variation in these membrane transporters [22] by deter-
mining new structures using the CSMP crystallographic
pipeline.
The annotation pipeline was used to provide target input
for a structural genomics project that successfully cloned,
expressed, and puriﬁed 61 of our ﬁrst 96 selected targets.
Furthermore, the methodology was applied to more general
problems in membrane protein biology: First, to explore
the evolutionary history of the substrate-binding trans-
membrane domains of the clinically important human ABC
transporter superfamily. Second, to identify the multidrug
resistance-associated (MDR) membrane proteins in whole
genomes and compare the MDR capacity of different
organisms. Finally, the pipeline was used to identify
putative new membrane protein families.
Materials and Methods
Membrane protein annotation pipeline
The overall process consisted of ﬁve steps (Fig. 1).
Step 1: Identiﬁcation of Pfam membrane protein families
All sequences from the curated Pfam database, Pfam-A
[11], were run through the TMHMM2.0 program [19].
Pfam families with sequences containing three or more
TMHs were identiﬁed as IM protein families.
Step 2: Sequence collection and membrane protein
sequence deﬁnition
Protein sequences from the genomes of 34 organisms
representing each of the three major kingdoms of life were
collected from UniProt [38], Ensemble [18], and
sequencing projects (Fig. 2). The TMHMM2.0 program
[19] was used to predict all sequences with three or more
TMHs (queries).
There are many algorithms available for predicting
transmembrane helices. A recent analysis of 13 trans-
membrane helix prediction programs found that four
methods, including TMHMM2.0, were consistently high-
performing in predicting transmembrane helices in mem-
brane proteins of known structure [3]. TMHMM2.0 was
selected for its relative accuracy as well as its speed and the
option to install it on our computers, which was essential
due to the large number of sequences processed.
The cutoff of three transmembrane helices was chosen
to focus on integral membrane proteins rather than mono-
topic or membrane-associated proteins that may only have
membrane anchoring helices or signal peptides. Such a
restriction ignores some important classes of integral
membrane proteins, such as one- and two-crossing proteins
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123that oligomerize to form channels. However, robust auto-
mated identiﬁcation of secretory signals for eukaryotes
remains a difﬁcult problem due to the diversity and lack of
characterization of sorting signals to different compart-
ments and incorrect identiﬁcation of signal peptides as
TMHs [9, 10]. Therefore, to restrict our work to integral
membrane proteins, proteins with only one or two pre-
dicted TMHs were discarded.
Step 3: Sequence proﬁles, family and taxonomic
classiﬁcation
The automated comparative modeling pipeline MODPIPE
was used to construct multiple sequence proﬁles. Sequen-
ces homologous to each of the query membrane proteins in
each organism were identiﬁed by iteratively searching the
UniProt database using the proﬁle.build() module of
MODELLER [29] with a threshold e-value of 0.01. Pro-
ﬁle.build() uses dynamic programming for aligning proﬁles
against sequences and an empirical deﬁnition of statistical
signiﬁcance based on the scores collected during the scan
of the database. For each proﬁle, every sequence was
linked back to its NCBI taxonomy browser identiﬁer and to
Pfam protein family annotations (if available) through the
MODBASE [30] database of comparative models. Each
query without a Pfam identiﬁer inherited the Pfam identi-
ﬁer of the most similar membrane protein in the same
proﬁle (parent); the query-parent alignment had to cover at
least 75% of the parent. For some queries, this procedure
does not result in a Pfam identiﬁer.
Step 4: Relationships between membrane
protein families
To link membrane protein families across the tree of life,
a database of the target sequence proﬁles was generated.
For each query, the proﬁle database was scanned using
the proﬁle.scan() routine in MODELLER for signiﬁcant
hits, corresponding to e-values smaller than 1. Bench-
marking indicates this cutoff results in a true positive rate
of 64.5% and a false positive rate of 0.03%. The false
positive rate indicates approximately 3 errors per 10,000
matches (Eashwar et al., in preparation). The scans link
membrane proteins both within organisms and across
organisms.
Step 5: Assessing modeling leverage
The MODWEB comparative modeling server was used to
generate models for all sequences homologous to seven
CSMP atomic resolution membrane protein structures.
MODWEB (http://salilab.org/modweb) is an integral
module of the MODBASE (http://salilab.org/modbase)
database of comparative models. MODWEB calculates a
proﬁle for each identiﬁable sequence homolog in the
UniProt database, followed by modeling these homologs
based on detectable templates in the PDB [30].
Fig. 1 Membrane protein annotation pipeline. All Pfam-A families
with at least three predicted transmembrane helices (TMH) were used
to identify membrane protein families in 34 genomes (cyan).
Sequences predicted to have three or more TMHs in each genome
were collected (red). In parallel, Pfam family membership was
deﬁned where available for each sequence proﬁle (yellow). Auto-
mated multiple sequence alignment proﬁles were generated for each
sequence. A database of proﬁles was constructed, and each proﬁle
was compared to all other proﬁles in the database to link membrane
proteins (blue). The annotation pipeline can be generally used as input
to an experimental structure determination pipeline. Finally, resulting
structures can be used as templates to generate comparative models
for all homologous sequences. The ﬁve steps are detailed in Methods
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123Fig. 2 PFAM membrane
protein families in 34
organisms. Organism names are
listed horizontally at the top
(columns). 476 Pfam membrane
protein families are on the
vertical axis (rows). Colors
indicate binning for the number
of times a particular family
appears in an organism. White
indicates a particular family is
not found in an organism; light
blue means the family appears
once; medium blue, between
two and 49 times; and dark blue
means the family is found 50 or
more times. The red and yellow
bars show the clustering of
eukaryotes and prokaryotes,
respectively. The heatmap was
constructed using the R function
‘‘heatmap.2’’ with hierarchical
clustering and default
parameters [37]
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123Assessing membrane protein model quality
To ensure that the ZDOPE score, which was developed
using a globular protein set, was suitable for use on
membrane proteins, Z-score distributions for 145 and
36,786 known IM and globular protein structures, respec-
tively (Supplementary Fig. 4) were compared. The aver-
ages are -0.63 and -1.56, respectively, suggesting that the
Z-score is still informative about the accuracy of membrane
protein structures. A Z-score cutoff of 0 was used to assess
models of membrane proteins.
Two-dimensional visualization of membrane protein
family associations
Each membrane protein proﬁle is represented as a node. If
two proﬁles are signiﬁcantly similar, as deﬁned above, an
edge is drawn between them. Sets of similar proﬁles will
cluster together because many proﬁles will be highly linked
to each other. Cytoscape is used to visualize the links
between membrane protein proﬁles and the layout algo-
rithm implemented in yFiles organic is used to display the
graph [36]. Distances between nodes on the graph are
representative of the number of links between the nodes;
sets of nodes which all link to each other tend to cluster
closely in space.
Identiﬁcation of unannotated homologs in seven
membrane protein families related to multidrug
resistance
The annotation pipeline was used to search for sequences
in seven families with experimentally established links to
multidrug resistance (MDR) in 34 organisms. The Pfam-A
families associated with MDR included: three ABC trans-
porter subtypes (PF06472, PF01061, and PF00664); Mul-
tidrug and toxic compound extrusion (MATE) transporters
(PF01554); small multidrug resistance family transporters
(PF00893), Golgi 4-TMH transporters (PF03821), and the
AcrBDF family (PF00873) (Supplementary Table 3). All
sequences annotated with one of these families were
collected and examined for differences in MDR across
organisms.
Identifying connections between human ABC
transporter transmembrane domains
Most human ABC transporters contain both membrane and
globular domains. To examine the evolutionary relation-
ships between the substrate-binding membrane domains, 72
TMDs from 48 human ABC transporters were excised from
the complete sequences for each transporter. Sequence
proﬁles were generated for the membrane sequences using
proﬁle.build() as described above. The ABC TMD proﬁles
were scanned against the IM database using proﬁle.scan() to
identify all related proteins in the 34 organisms.
Identiﬁcation of new membrane protein families
Sequences that could not be annotated with a Pfam-A
membrane protein family were identiﬁed. For each of the
4,389 proﬁles associated with these sequences, all hits in
each proﬁle were annotated with an NCBI taxonomy ID
and the root taxonomy was recursively determined at the
kingdom level. This procedure results in a classiﬁcation of
each proﬁle as either exclusively related to one kingdom
(i.e., all hits to the proﬁle are eukaryotic, bacterial, or
archaeal) or as some combination of the three kingdoms.
To reduce the likelihood of spurious classiﬁcation of
new membrane protein families, the following restrictions
were imposed: First, only single-kingdom classiﬁed
sequences were considered when deﬁning new families.
All single-kingdom sequences were examined for hits to
the IM database and clusters of sequences with more than
four members were considered putative new families.
Second, proﬁle-proﬁle alignments were calculated for all
members in each putative cluster the overlap in each
alignment of predicted TMHs was computed. To be deﬁned
as a new family, at least half of the TMHs in a proﬁle had
to have better than 60% coverage in all proﬁle-proﬁle
alignments of the target against all other targets in the
cluster. Sequences representing new families were run
against the Pfam-A and Pfam-B databases to determine if
either database had a corresponding family. Pfam-B is an
automatically generated, uncurated clustering of domains
identiﬁed using the ADDA program [15].
Results
Membrane protein annotation pipeline
The annotation pipeline consists of ﬁve main steps (Fig. 1,
Methods). In the ﬁrst step, we started with 1,779,528
sequences in Pfam-A (01/09/07) [11]. Of these, 172,079
are predicted by TMHMM [21] to have one or more
transmembrane a-helices (TMHs); 99,937 have three or
more TMHs. Because of the difﬁculty of accurately iden-
tifying signal peptides and possible errors in TMH
prediction, only integral membrane protein sequences
predicted to have at least three TMHs. These sequences
belong to 598 unique Pfam families (Supplementary
Table 1) were selected, of which 476 appear in at least one
of the 34 organisms of interest (Fig. 2). Organisms
were selected based on the following considerations:
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human disease, diversity within each kingdom, and the
availability of genomic DNA for cloning and expression.
The 122 families with no representatives include: photo-
system-related families (e.g., PF00421) that are not found
in any of the selected organisms, families that are only
found in a single organism (e.g., PF03303), and families
with no characterized function (e.g., PF06836 and
PF07099).
In the second step, sequences for the 34 genomes were
collected from UniProt, Ensemble and organism-speciﬁc
sequencing projects. In total, there were 21,379 proteins
predicted to have at least three TMHs, corresponding to the
‘‘integral membrane genomes’’ (IMGs) of the 34 organisms
(Supplementary Fig. 1). We were able to annotate between
41% (Plasmodium falciparum) and 93% (Mus musculus)o f
each IMG with Pfam family IDs; 16 of the genomes had
more than 25% of their IMG unannotated, suggesting that
there are many undiscovered membrane protein families.
In the third step, for each protein, an automated multiple
sequence alignment of the corresponding superfamily was
generated, represented by a position-speciﬁc scoring matrix
(PSSM), and added to a database, which we call the
integral membrane (IM) database (http://salilab.org/projects/
integral_membrane_proteins/34pssmdb.txt.gz).
In the fourth step, each PSSM was compared to the
whole IM database, using proﬁle-proﬁle alignments to
identify related proteins.
The ﬁfth step estimated the impact of newly solved
atomic-resolution structures on the coverage of membrane
protein sequence space. While it would be ideal to use
crystal structures resulting from the target selection pipe-
line described here, our experimental pipeline based on
yeast expression has not yet yielded any structures. To
demonstrate the utility of this ﬁnal step in the pipeline, we
therefore use other recently solved membrane protein
structures that were not part of our yeast target selection
scheme. As of October 2008, the CSMP determined crys-
tallographic structures for the following seven integral
membrane proteins: the Escherichia coli Ammonia Chan-
nel Amtb (PDB ID: 2ns1), the Nitrosomonas europaea
Rh50 Ammonium transport protein (PDB ID: 3bhs), two
structures of E. coli lactose permease (PDB IDs: 2cfq,
2v8n), the archaeal aquaporin AqpM (PDB ID: 2f2b), a
mutant structure of E. coli AqpZ (PDB ID: 2o9d), and an
aquaglyceroporin from Plasmodium falciparum (PDB ID:
3c02).
These seven structures fall into three Pfam protein
families: the ammonia channel and ammonium transport
protein are members of the PF00909 ammonium trans-
porter family, the two aquaporins and the aquaglyceroporin
are members of the PF00230 major intrinsic protein (MIP)
family, and lactose permease is a member of the PF01306
LacY proton/sugar transporter family. The structures were
used as input to the ﬁnal step of the computational pipeline
to calculate how many sequences can be modeled based on
these structures (i.e., the modeling leverage).
To assess the value of each new CSMP template for
comparative modeling, models for sequences that could be
modeled using both a CSMP structure and any non-CSMP
membrane structure as templates were compared. To take
partially modeled sequences into account, the comparison
is performed at the residue level. Additionally, a ‘‘trans-
membrane region’’ was deﬁned for each of the CSMP
template structures that included all amino acid residues
from the ﬁrst TMH residue to the last TMH residue.
There were a total of 178,627 sequences for all mem-
brane template-based modeling calculations, 13,317 of
which were sequences based on CSMP templates. Of this
set, 11,240 sequences with 1,108,633 residues in trans-
membrane regions could be modeled using both a CSMP
template and another template. 18% of the residues
(199,684) were modeled with higher target-template
sequence identity with a CSMP template than any other
available membrane protein structure, demonstrating the
value of these additional structures for comparative mod-
eling of membrane proteins. For individual models, the
lactose permease structures had the best modeling leverage,
with 24% of residues modeled with higher target-template
sequence identity using the CSMP structures 2v8n and
2cfq. The aquaporin and aquaglyceroporin structures (2f2b,
2o9d, and 3c02) had less impact, with 8% of residues
modeled the best with the CSMP template (Supplementary
Table 2).
Calculating the impact of new membrane protein
structures on coverage of membrane protein sequence
space will aid in assessing target selection efforts by
structural genomics consortia. Furthermore, this modeling
approach is applicable to any new membrane protein
structure.
Membrane protein family distribution in the three
kingdoms of life
All sequences representing membrane protein families
from each genome were collected and the number of
times each family appeared in each genome was counted.
Counts were assembled into a matrix (http://salilab.org/
projects/integral_membrane_proteins/memb_counts.txt.gz).
The counts ranged from 0 counts of a family in an
organism to 1,468 for rhodopsin-like GPCRs in the mouse
genome, demonstrating that some families are highly
represented in multiple genomes and others are rare or
restricted to only a few organisms. There are 13,139, 2,079,
1,956, and 30 families with 0, 1, 2–49, and 50–1468 rep-
resentatives, respectively.
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membrane proteins in yeast
Two subsets of target proteins for structural studies were
selected. First, we aimed to maximize the coverage of the
Saccharomyces cerevisiae IMG while minimizing the
number of targets for expression. Second, we also selected
a number of targets to further PMT’s functional and clin-
ical studies of ABC and SLC membrane transporters in
drug disposition.
Target selection for sequence leverage
Pfam annotations were used to cover all membrane protein
families in yeast and the associations between multiple
sequence proﬁles were used to select sequences that are
absent from Pfam (Methods). There are 621 predicted IM
sequences in yeast and these were the input to our com-
putational annotation pipeline. Of these, 490 sequences
could be annotated with 165 unique Pfam membrane pro-
tein families and 131 could not be annotated with a Pfam
identiﬁer. Of the 165 annotated families, 79 were repre-
sented by a single sequence, meaning the family appeared
only once in the yeast genome.
The 79 singletons initiated our target list. For the
remaining 83 annotated families, two sequences were
selected from each family to improve the likelihood of
successful structural characterization for that family. These
two members were selected to ensure optimal coverage of
each family (Methods), which is especially important for
larger families. For example, the major facilitator family
(MFS) has 57 sequences, the most of any membrane pro-
tein family in yeast. The MFS sequences fall into two
major clusters, one with 44 MFS members and one with
six. VBA1_YEAST, which is associated with 24 MFS-
annotated sequences in the ﬁrst cluster (55%) and
MCH4_YEAST, which is associated with ﬁve MFS
sequences in the second cluster (83%) were selected.
Of the 131 unannotated sequences, 16 were in two
completely unannotated clusters of 8 sequences each, 62 hit
no other sequences, six sequences fell in two unannotated
clusters of three sequences each, and 14 fell into seven
clusters of two sequences each. The remaining 33
sequences were associated with at least one other annotated
sequence and were discarded. Because two sequences were
selected from each unannotated cluster, there are an addi-
tional 98 targets. Complete coverage of the yeast genome
therefore requires 347 targets out of the 621 IMG proteins.
If a target fails in any stage of the experimental process, a
similar yeast target can be selected for a subsequent trial
[23].
The results of our computational annotation pipeline
were entered into an experimental structure determination
pipeline, as detailed in the Results and Discussion and a
companion paper [23].
Target selection for biological signiﬁcance
Two of the targets, the yeast genes STE6 and YN_99, code
for ATP-binding cassette transporters that are homologous
to human multidrug transporters in the B and G families,
respectively. There are 48 characterized ABC transporters
in the human genome and 18 are disease-associated [7, 8,
26]. There are many atomic structures available for isolated
nucleotide binding domains (NBDs) from ABC transport-
ers, and these structures have been successfully used to
assess the role of interface-disrupting point mutants with
clinical phenotypes in human ABC transporters [20].
However, a molecular level understanding of the clinical
impact of genetic variation requires high-resolution struc-
tural data for the substrate-binding transmembrane
domains (TMDs) of these proteins, providing the rationale
for their inclusion into the target list.
In humans, ABCB1 (also known as MDR1) and other
members of the B family, such as ABCB4 (MDR3) and
ABCB11 (BSEP), are associated with multidrug resistance
in cancer therapy. ABCB4 and ABCB11 are also associ-
ated with several forms of cholestasis [13]. Our collabo-
rators at the PMT have identiﬁed 29 non-synonymous
single nucleotide polymorphisms in these proteins. The
STE6 structure would be particularly useful for structural
modeling of sequence variations in humans because the
domain organization of two TMDs and two nucleotide-
binding domains NBDs is the same as in the human
transporters ABCB1, ABCB11 and ABCB4 (Supplemen-
tary Fig. 2). The most similar structurally characterized
homolog of the ABCB family is currently the Staphylo-
coccus aureus transporter Sav1866 [5]. This transporter has
only a single TMD and a single NBD that forms a
homodimer; thus, it is not an ideal template for modeling
the four domain multidrug resistance-associated transport-
ers from the ABCB family.
The yeast nucleoside transporter target YAL022C
(FUN26) [39] is homologous to the equilibrative nucleo-
side transporters ENT1 (SLC29A1) and ENT2 (SLC29A2).
The PMT has identiﬁed two non-synonymous SNPs in
SLC29A1as well as two non-synonymous SNPs and seven
insertion/deletion mutations in SLC29A2 [22].
Additional structural data from these transporter fami-
lies will be invaluable for interpreting the results of func-
tional studies and suggesting molecular mechanisms for
clinical phenotypes.
The ﬁnal set of 384 targets was entered into the struc-
tural characterization pipeline of the CSMP [23]. Of these
targets, 273 are signiﬁcantly related to at least one human
gene. In all, 1,249 human sequences are signiﬁcantly
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40% of the human IMG has a corresponding gene in yeast
(Supplementary Fig. 3a, b). Our clustering of the yeast
IMG is generally in agreement with the manual ‘‘clans’’
clustering in Pfam (Supplementary Fig. 3c) [11].
Deﬁning the scope of membrane protein structural
genomics
The scope of structural genomics of membrane proteins is
the number of target structures needed to achieve some
desired coverage of the membrane protein sequence space.
Current comparative modeling coverage of integral mem-
brane protein sequences in UniProt [38] was examined
ﬁrst. Next, the total number of structures required for
desired sequence coverage of the 598 Pfam integral
membrane protein families described above was calculated.
The ModBase database [30] contains 806,266 models of
1,733,721 sequences the complete UniProt (as of 6/1/2005)
for which the target-template identity is at least 30%. Of
these, 61,749 models for 55,161 unique sequences are
predicted by TMHMM to contain at least three TMHs. This
estimate suggests that domains in only approximately 8%
of integral membrane proteins can be currently modeled at
reasonable accuracy (implied by the 30% target-template
sequence identity) using available template structures
(Supplementary Fig. 4).
To improve the coverage, it would be ideal to select
sequences for structural characterization that yielded the
greatest improvement in the number of modelable
sequences based on the 598 Pfam integral membrane
families. At 30% sequence identity, the 375,155 sequen-
ces in these families fall into 13,395 clusters. Thus, a
representative structure from such a cluster provides a
reasonable template for comparative modeling of the
other sequences in its cluster. Using a target selection
strategy where sequences from the largest clusters are
selected for structural characterization ﬁrst, 90% of the
sequences in the currently known integral membrane
families could be covered by 2,454 structures. In contrast,
a random selection of crystallographic targets would
require approximately eight times more structures (i.e.,
20,000) to achieve the same coverage. For 70% coverage
of sequence space, a more realistic goal, the ranking by
cluster size requires 504 structures versus 2,500 for the
random selection (Fig. 3).
Applications of the membrane protein annotation
pipeline
Identiﬁcation of unannotated homologs in seven membrane
protein families related to multidrug resistance
In the 34 genomes, 793 sequences were annotated as
coming from one of seven Pfam-A families with experi-
mentally established links to multidrug resistance (MDR).
Of these sequences, 292 were not described by either the
‘‘Protein name’’ ﬁeld in UniProt or the ‘‘DEFINITION’’
ﬁeld in Genbank as MDR-related, but rather with
descriptions such as ‘‘conserved membrane protein’’ or
‘‘uncharacterized protein’’.
Between 2% (mouse) and 8% (Mycobacterium tuber-
culosis) of the IMG of each organism is devoted to MDR.
Furthermore, pathogenic organisms tend to have higher
percentages of MDR membrane proteins in their genomes.
For example, the pathogens M. tuberculosis, Cryptospori-
dium parvum, Cryptosporidium hominis, Pseudomonas
aeruginosa, and Leishmania major, and the obligate para-
site Mycoplasma pneumoniae all had more than 5% of their
IMGs devoted to MDR.
Tracing the evolutionary history of human ABC
transporters
ABC transporters are found in all three kingdoms of life.
These proteins couple ATP binding, hydrolysis, and release
to substrate transport across a membrane. They share a
common architecture consisting of combinations of trans-
membrane domains (TMDs) and nucleotide-binding
domains (NBDs). While the NBDs are well conserved, the
TMDs, which contain the substrate binding sites, are more
divergent.
The 72 TMDs in the human ABC transporter super-
family were associated with 669 unique sequences in the
34 organisms. In total, there were 16,503 connections
between the human TMDs and sequences in the IM data-
base (Fig. 4).
Fig. 3 Target selection for membrane protein structural genomics.
Structural coverage of the known IMG (Integral Membrane Genome)
sequence space was deﬁned by taking sequences from 598 IM Pfam
families and clustering them at 30% sequence identity
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123Identiﬁcation of new membrane protein families
Finally, the analysis suggests that there exist additional
unidentiﬁed membrane protein families. Out of the 21,385
sequences of membrane proteins in the selected genomes,
4,389 (21%) could not be annotated with a Pfam membrane
protein family.
Of the 51 putative new families, 27 and 16 had one or
more Pfam-B identiﬁers, respectively (11/10/08). Because
groups of TMHs may act as a functional unit, a family
deﬁnition needs to cover as long a stretch of conserved
TMHs as possible; our analysis extends the membrane
region coverage of 10 Pfam-A families. For example, in
Eukaryotic cluster 14, the analysis indicates a conserved
group of 3 TMHs, whereas the Pfam-A family hit
Mpv17_PMP22 (PF04117) covers either one or two of the
TMHs. Furthermore, the latest version of Pfam-A now
includes new families, such as DuoxA (PF10204), Tmp39
(PF10271), and DUF2453 (PF10507) that each correlate
with one of our newly identiﬁed eukaryotic families.
Finally, Bacterial Cluster 4 has no Pfam-A or B classiﬁ-
cation in the conserved membrane region.
Discussion
Membrane protein family distribution in the three
kingdoms of life
Simply using the family compositions of the IMGs,
eukaryotic and prokaryotic organisms are clearly distin-
guishable (Fig. 2). This discrimination was robust with
respect to binning and may be useful for identifying the
kingdoms of the source organisms in large-scale environ-
mental sequencing projects. Furthermore, some limited
information on how organisms communicate with the
environment is recovered. Two organisms, the bacterium
Mycoplasma pneumoniae and the hyperthermophilic ar-
chaeon Nanoarchaeum equitans, cluster with each other
rather than with their respective kingdoms. These organ-
isms are obligate parasites, dependent on a host for survival,
with small genomes and highly permeable membranes, thus
presumably requiring similar IMGs [14, 24].
Target selection for the structural genomics of integral
membrane proteins in yeast
Our annotation pipeline provided a comprehensive set of
sequences covering all IM protein families in yeast as input
to a structural genomics project. Despite high failure rates
in membrane protein crystallography, 23 targets out of the
ﬁrst set of 96 targets were rapidly identiﬁed that expressed,
were fully soluble in DDM, and were within the included
volume of a size exclusion column. The ﬁrst ﬁve of these
targets were subsequently demonstrated to be stable within
the assigned buffer and easily puriﬁed using established
protocols. Finally, three of the top targets crystallized
readily from standard sparse matrix screens [23].
A 24% return of identiﬁed targets from the original
starting subset of 96 targets demonstrates that our com-
bined computational and experimental pipeline can be
successfully used to identify and prioritize eukaryotic
integral membrane proteins for downstream crystallization
and functional characterization. Future improvements
could include considering a number of protein attributes,
such as presence of disordered regions or protein interac-
tion partners correlate with reduced odds of puriﬁcation
and crystallization.
One goal of structural genomics is to increase the
number and variety of sequences that can be modeled with
useful accuracy by comparative modeling [2]. Finding
sequences that can be modeled based on a given template
structure is the ﬁrst step in this modeling process. The
Fig. 4 Links between the transmembrane domains of human ABC
transporters. The transmembrane domains of 48 human ABC
transporter proteins were excised from their complete sequences.
Proﬁles were generated for each transmembrane domain and run
against the membrane protein proﬁle database (Methods). Signiﬁ-
cantly related proﬁles are linked and colored according to organism
with red, blue, and yellow representing eukaryotes, bacteria, and
archaea, respectively. The two major clusters represent ABCA and G
family members (dark and light green); and ABCB, C, and D family
members (purple)
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for how many sequences could have at least three predicted
TMHs modeled based on at least 30% sequence identity to
the template structure (i.e., sequence leverage) [34]. The
structures of our 384 selected yeast targets would enable
the modeling of 63,584 UniProt sequences based on at least
30% sequence identity between the selected target and its
homologs. Of these, 18,633 sequences were predicted to
have at least three TMHs in the model. Thus, the sequence
leverage of the 384 targets is 18,633. For comparison, 384
randomly selected yeast membrane protein structures
would enable the modeling of a similar number of mem-
brane sequences, but on average would cover 34 fewer
families out of 162 total identiﬁed Pfam families in yeast.
Deﬁning the scope of membrane protein structural
genomics
Despite their relevance to human health and importance in
cellular gatekeeping, regulation and sensing, the number of
solved, high-resolution structures of membrane proteins is
low. There are currently 94 a-helical integral membrane
protein structures with less than 95% sequence identity to
each other from 37 Pfam families with at least three TMHs.
Of the structures solved, some, like the bacterial rhodop-
sins and the aquaporins, share the same fold. This dearth of
structures and lack of diversity contribute to incomplete
annotation of membrane protein sequences. Additional
coordination in target selection for the structural genomics
of membrane proteins, such as the selection proposed here,
would greatly facilitate comprehensive accounting of
membrane protein families and contribute to their func-
tional annotation.
Other recent work predicted the number of structures
required to cover membrane protein sequence space.
Approximately 80% of membrane protein sequence space
represented by sequences from 95 genomes can be orga-
nized into approximately 700 families (ignoring families
with singleton members) [28]. A study of bacterial proteins
predicted by TMHMM2.0 to have at least three TMHs
suggested that 242 new structures would provide structural
coverage at the fold level of approximately 70% of
sequences belonging to the most populated prokaryotic
membrane protein families [25].
For 80% coverage of membrane protein sequence space,
our analysis requires approximately 1073 structures; this
higher number is likely a consequence of including all
genomes represented in Pfam instead of only 95 select
genomes and highlights the importance of including as
many identiﬁable protein families as possible. Our analysis
suggests that 504 structures would cover 70% of membrane
protein sequence space; this larger number is likely a result
of including eukaryotic proteins in our analysis. The
difﬁculty of membrane protein crystallization makes it
likely that it will be many years before the goal of complete
structural coverage of membrane protein families is
achieved.
Application of the membrane protein annotation
pipeline
Identiﬁcation of multidrug resistance associated
transporters
Identifying binding sites and predicting substrates for
membrane proteins can be a more difﬁcult problem than for
their globular counterparts because they often lack clear
surface features, such as pockets and grooves, which sug-
gest binding sites. Many membrane proteins, including
MDR transporters, are multispeciﬁc, transporting a variety
of dissimilar substrates. In the case of a Haemophilus
inﬂuenzae ABC transporter, the endogenous substrate of
the protein remains unknown, even with a high-resolution
crystal structure [31]. The combination of sequence-based
evolutionary information with more diverse membrane
protein structures will be a powerful tool for identifying
putative substrates of uncharacterized membrane protein
sequences, for example by computational ligand docking
followed by experimental validation [16].
Tracing the evolutionary history of human ABC
transporters
The sequence proﬁle connections between the TMDs in
human ABC transporters reveal two major clusters of
sequences. The TMDs from ABC transporter families A
and G clustered together and that families B, C, and D also
clustered together (Fig. 4). Prior sequence analysis found
that the nucleotide binding domains also cluster identically
[7, 8]. This congruence suggests that the TMDs and NBDs
of the human ABC transporters evolved from a common
ancestor with both domains intact on the polypeptide chain,
rather than evolving separately and then joining later in the
evolution of the protein.
Next, the taxonomy of associated clusters of TMDs was
analyzed to identify the breakdown of subfamilies by
kingdom. The ABCG family had a signiﬁcantly higher
representation of archaeal sequences than either the B, C, D
cluster or the A cluster (p-value = 2 9 10
-12, 2-sample
test for equality of proportions). The ABCA family had no
archaeal hits at all and few bacterial hits (9 out of 199 total
hits). This difference in taxonomic representation suggests
a possibly more ancient origin for the ABCG family and a
more recent origin for the ABCA family.
The ABCA family has undergone many gene duplica-
tion and loss events [6] and the complement of 12 ABCA
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123genes in the human genome may primarily transport mol-
ecules endogenous to eukaryotic organisms. One example
is the photoreceptor cell-speciﬁc ABCA4 gene [6]. In
contrast, the more taxonomically diverse sterol-transport-
ing ABCG genes may represent more general mechanisms
of lipid distribution. Due to their promiscuity, the full range
of the ABC transporter substrates is currently not known.
The membrane domain alignments described here will be
used to suggest likely overlapping substrate speciﬁcities
among these clinically relevant human transporters and
their orthologs in other organisms.
Identiﬁcation of new membrane protein families
While many of the clusters produced by the annotation
pipeline had Pfam-B identiﬁers, Bacterial Cluster 4 has no
Pfam-A or B classiﬁcation in the conserved membrane
region. The members in this cluster come from the path-
ogenic gram-negative bacteria Pseudomonas aeruginosa,
Burkholderia mallei, Yersinia pestis, and Rickettsia prow-
azekii. The sequences contain between nine and 11 TMHs.
The conserved region covers eight TMHs. Two of the
sequences contain a non-transmembrane domain, Wzy_C
(PF04932), that is involved in the synthesis of a lipopoly-
saccharide O-antigen found in the outer membrane of
gram-negative bacteria. It is possible that the conserved
membrane region found in this cluster is involved in a set
of the transport process of synthesized lipopolysaccharides
to the outer membrane in gram-negative bacteria.
The validity of this analysis is demonstrated by the
agreement of our classiﬁcation with both Pfam-A and B,
alternative classiﬁcations that were done using different
methods; the reclassiﬁcation in this analysis to include
complete transmembrane regions in putative families; and
the identiﬁcation of a bacterial family possibly involved in
lipopolysaccharide synthesis and transport.
Conclusion
A membrane protein annotation pipeline was developed to
deﬁne the integral membrane genome and associations
between 21,379 proteins from 34 genomes; most, but not
all of these proteins belong to 598 deﬁned families. The
annotation pipeline was used to provide target input for a
structural genomics project that successfully cloned,
expressed, and puriﬁed 61 of our ﬁrst 96 selected targets.
Furthermore, the methodology was applied to unsolved
problems in membrane protein biology, including explor-
ing the evolutionary history of the substrate-binding
transmembrane domains of the human ABC transporter
superfamily, locating sets of multidrug resistance-associ-
ated membrane proteins in whole genomes, and identifying
putative new membrane protein families. While most pre-
dicted membrane proteins are assigned to an annotated
protein family, a quarter or more of the membrane proteins
in 16 of the 34 studied organisms remain unassigned,
highlighting a need for large-scale structural and functional
characterization of membrane proteins.
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